WordNet

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

The Quality of Curative-intent Radiotherapy for Non-small Cell Lung Cancer in the UK.

McAleese J1, Baluch S2, Drinkwater K3.
Clinical oncology (Royal College of Radiologists (Great Britain)).Clin Oncol (R Coll Radiol).2015 Sep;27(9):498-504. doi: 10.1016/j.clon.2015.05.006. Epub 2015 Jun 12.
AIMS: Lung cancer is the leading cause of cancer-related death in the UK. The quality of curative-intent radiotherapy is associated with better outcomes. National quality standards from the National Institute for Health and Care Excellence (NICE) on patient work-up and treatment selection were used,
PMID 26073694

The UK experience of a treatment strategy for pediatric metastatic medulloblastoma comprising intensive induction chemotherapy, hyperfractionated accelerated radiotherapy and response directed high dose myeloablative chemotherapy or maintenance chemotherapy (Milan strategy).

Vivekanandan S1, Breene R2, Ramanujachar R3, Traunecker H4, Pizer B5, Gaze MN6, Saran F7, Thorp N8, English M9, Wheeler KA10, Michalski A11, Walker DA12, Saunders D13, Cowie F14, Cameron A15, Picton SV16, Parashar D17, Horan G1, Williams MV1.
Pediatric blood & cancer.Pediatr Blood Cancer.2015 Aug 14. doi: 10.1002/pbc.25663. [Epub ahead of print]
BACKGROUND: Historically, the 5-year overall survival (OS) for metastatic medulloblastoma (MMB) was less than 40%. The strategy of post-operative induction chemotherapy (IC) followed by hyperfractionated accelerated radiotherapy (HART) and response directed high dose chemotherapy (HDC) was reported
PMID 26274622

Metastatic medulloblastoma in adults: Outcome of patients treated according to the HIT2000 protocol.

von Bueren AO1, Friedrich C2, von Hoff K3, Kwiecien R4, Müller K5, Pietsch T6, Warmuth-Metz M7, Hau P8, Benesch M9, Kuehl J10, Kortmann RD5, Rutkowski S3.
European journal of cancer (Oxford, England : 1990).Eur J Cancer.2015 Aug 5. pii: S0959-8049(15)00650-4. doi: 10.1016/j.ejca.2015.06.124. [Epub ahead of print]
BACKGROUND: Due to the rarity of metastatic medulloblastoma in adults, knowledge about the efficacy and toxicity of intensified chemotherapy and radiotherapy is limited.PATIENTS AND METHODS: Adults with disseminated medulloblastoma registered in the HIT2000 trial as observational patients and treate
PMID 26254812

田畑貴久,若杉哲郎,三箇敏昭 [他],北村拓朗,永谷群司,鈴木秀明
耳鼻咽喉科臨床 108(4), 295-300, 2015
… Patients with T1b glottic or T2 cancer received hyperfractionated radiotherapy with concurrent daily carboplatin (25 mg/m2). … Responders among the T3 patients were given hyperfractionated radiotherapy with concurrent daily carboplatin, whereas all T4 patients and nonresponder T3 patients were treated by surgery after induction chemotherapy.The overall 5-year crude survival, disease-specific survival and laryngeal preservation rates as determined by the Kaplan-Meier method were 73.5%, 81.9% and 64.2%, respectively. …
NAID 130005061541

Initial Evaluation on the Safety and Efficacy of Accelerated Hyperfractionated Radiotherapy for Locally Advanced Cervical Cancer: A Pilot Study

玉置幸久,吉田理佳,Takahashi Satoru,Kawabe Tetsuya,Murakami Masao,楫靖,Nakazawa Masanori,Fukazawa Kazuo,吉廻毅,北垣一,Sekihara Kazumasa,稗田洋子,猪俣泰典
Shimane journal of medical science 30(2), 77-86, 2014-01-01
… We used the accelerated hyperfractionated radiotherapy of locally advanced cervical cancer and assessed the initial treatment efficacy and safety.This study enrolled three patients. …
NAID 120005587556